Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neurofibromatosis 1 2Carcinoma, Hepatocellular 2Weight Loss 1Ulcer 1Tongue Neoplasms 1Stomatitis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Radiation-Induced Mucositis 1Radiation Pneumonitis 1Pseudomyxoma Peritonei 1Primary Graft Dysfunction 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Ototoxicity 1Neoplasms, Cystic, Mucinous, and Serous 1Muscular Atrophy 1Mucositis 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Neoplasms 1Liver Failure, Acute 1Liver Failure 1Liver Diseases 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Head and Neck Neoplasms 1

Interventions

Ipilimumab 106Nivolumab 101pembrolizumab 90aldesleukin 72Cyclophosphamide 46Interleukin-2 45Temozolomide 36Dacarbazine 32trametinib 31dabrafenib 30fludarabine phosphate 29incomplete Freund's adjuvant 27Bevacizumab 26sargramostim 25Vemurafenib 25fludarabine 22binimetinib 21Radiosurgery 21Paclitaxel 20encorafenib 19Carboplatin 19CTLA-4 Antigen 18cobimetinib 16atezolizumab 15Radiotherapy 14Biopsy 14Sorafenib 13MART-1 Antigen 12talimogene laherparepvec 11montanide ISA 51 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Melanoma × Acetylcysteine × Clear all
NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
80 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡